Literature DB >> 11738057

Postinfarction heart failure in rats is associated with upregulation of GLUT-1 and downregulation of genes of fatty acid metabolism.

N Rosenblatt-Velin1, C Montessuit, I Papageorgiou, J Terrand, R Lerch.   

Abstract

OBJECTIVES: Increasing evidence suggests that left ventricular remodeling is associated with a shift from fatty acid to glucose metabolism for energy production. The aim of this study was to determine whether left ventricular remodeling with and without late-onset heart failure after myocardial infarction is associated with regional changes in the expression of regulatory proteins of glucose or fatty acid metabolism.
METHODS: Myocardial infarction was induced in rats by ligation of the left anterior descending coronary artery (LAD). In infarcted and sham-operated hearts the peri-infarction region (5-mm zone surrounding the region at risk), the interventricular septum and the right ventricular free wall were separated for analysis.
RESULTS: At 8 and 20 weeks after LAD ligation, the peri-infarction region and the septum exhibited marked re-expression of atrial natriuretic factor [+252+/-37 and +1093+/-279%, respectively, in the septum (P<0.05)] and of alpha-smooth muscle actin [+34+/-10 and +43+/-14%, respectively, in the septum (P<0.05)]. At 8 weeks, when left ventricular hypertrophy was present without signs of heart failure, myocardial mRNA expression of glucose transporters (GLUT-1 and GLUT-4) was not altered, whereas mRNA expression of medium-chain acyl-CoA dehydrogenase (MCAD) was significantly reduced in the peri-infarction region (-25+/-7%; P<0.05). In hearts exhibiting heart failure 20 weeks after infarct-induction there was a change in all three ventricular regions of both mRNA and protein content of GLUT-1 [+72+/-28 and +121+/-15%, respectively, in the peri-infarction region (P<0.05)] and MCAD [-29+/-9 and -56+/-4%, respectively, in the peri-infarction region (P<0.05)].
CONCLUSION: In rats with large myocardial infarction, progression from compensated remodeling to overt heart failure is associated with upregulation of GLUT-1 and downregulation of MCAD in both the peri-infarction region and the septum.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11738057     DOI: 10.1016/s0008-6363(01)00393-5

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  31 in total

Review 1.  Cardiac metabolism in heart failure: implications beyond ATP production.

Authors:  Torsten Doenst; Tien Dung Nguyen; E Dale Abel
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

Review 2.  A comprehensive review of the bioenergetics of fatty acid and glucose metabolism in the healthy and failing heart in nondiabetic condition.

Authors:  Ashish Gupta; Brian Houston
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

Review 3.  Glucose Transporters in Cardiac Metabolism and Hypertrophy.

Authors:  Dan Shao; Rong Tian
Journal:  Compr Physiol       Date:  2015-12-15       Impact factor: 9.090

4.  Myocardial energetics in left ventricular hypertrophy.

Authors:  Mohammad N Jameel; Jianyi Zhang
Journal:  Curr Cardiol Rev       Date:  2009-08

5.  Assessment of metabolic phenotypes in patients with non-ischemic dilated cardiomyopathy undergoing cardiac resynchronization therapy.

Authors:  Sebastian Obrzut; Jay Tiongson; Neema Jamshidi; Huy Minh Phan; Carl Hoh; Ulrika Birgersdotter-Green
Journal:  J Cardiovasc Transl Res       Date:  2010-09-15       Impact factor: 4.132

6.  A glucose-insulin-potassium solution improves glucose intake in hypoxic cardiomyocytes by a differential expression of glucose transporters in a metabolic syndrome model.

Authors:  R Carbo; E Rodriguez
Journal:  J Biosci       Date:  2019-03       Impact factor: 1.826

7.  Compensated cardiac hypertrophy is characterised by a decline in palmitate oxidation.

Authors:  Ashwin Akki; Katie Smith; Anne-Marie L Seymour
Journal:  Mol Cell Biochem       Date:  2008-02-16       Impact factor: 3.396

8.  Adult presentation of MCAD deficiency revealed by coma and severe arrythmias.

Authors:  F Feillet; G Steinmann; C Vianey-Saban; C de Chillou; N Sadoul; E Lefebvre; M Vidailhet; P E Bollaert
Journal:  Intensive Care Med       Date:  2003-08-01       Impact factor: 17.440

9.  Sarcolemmal fatty acid transport in normal and diseased hearts.

Authors:  Jan F C Glatz; Arend Bonen; Joost J F P Luiken
Journal:  Curr Hypertens Rep       Date:  2007-12       Impact factor: 5.369

10.  Myocardial metabolic regulation through peroxisome proliferator-activated receptor alpha after myocardial infarction.

Authors:  Katsuhiko Masamura; Nobuyoshi Tanaka; Masahiro Yoshida; Masayuki Kato; Yasuyuki Kawai; Koji Oida; Isamu Miyamori
Journal:  Exp Clin Cardiol       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.